Zealand Pharma Benefits Overview

Lead DMPK/ADME strategy for complex drug modalities, including peptides, antibodies, and conjugates. Build discovery and bioanalysis platforms, oversee PK studies, develop LC-MS and ligand-binding assays, assess metabolism and binding risks, interpret data, and deliver integrated DMPK packages for R&D decisions and regulatory documentation. Partner with CROs and cross-functional teams while advancing digital and automated workflows.

Leads research competitive intelligence for obesity and metabolic health, synthesizing publications, patents, press releases, congress data, and scientific landscapes. Applies quantitative and statistical methods to analyze preclinical and clinical datasets, develops executive-ready insights, and influences research strategy and portfolio decisions. Partners with Research, Medical, Development, Investor Relations, Commercial, Data & Technology, and IT teams while building repeatable intelligence workflows and incorporating AI systems.

Lead US HEOR and RWE strategy for metabolic portfolio, design and execute RWD and economic studies, develop AMCP dossiers and publications, engage payers and external partners, inform clinical development, and drive evidence-based commercialization decisions.